https://www.pharmanow.live/latest-news/artelo-biosciences-art2713-glp1-combination-weight-loss-nonclinical-data 2026-11-12T21:55:37+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Artelo Biosciences Achieves 40% Weight Loss in GLP-1 Combination Nonclinical Study Artelo https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/cccfbc34-751f-47ac-b535-61c39708cbf9.png https://www.pharmanow.live/latest-news/grace-therapeutics-dual-source-cmo-strategy-gtx-104-nda-resubmission 2026-11-12T21:57:41+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Grace Therapeutics Advances Dual-Source CMO Strategy Grace https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/00c59e34-7bd6-453e-ab1e-1a3a8626b50e.png https://www.pharmanow.live/latest-news/monopar-therapeutics-rolling-nda-submission-alxn1840-wilson-disease 2026-11-12T22:00:05+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Monopar Therapeutics Advances Rolling NDA Submission in Wilson Disease https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://ml.globenewswire.com/media/f8cee181-5ae9-4a02-84f5-6e35affbb72b/small/monopartherapeuticsinc-png.png https://www.pharmanow.live/latest-news/kiora-pharmaceuticals-kio-401-ind-pathway-senju-calpain-inhibitor 2026-11-12T21:59:20+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Kiora Pharmaceuticals Advances KIO-401 IND Pathway Kiora https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/b23a103c-844b-4208-a709-b6e1c7ce782d.png https://www.pharmanow.live/latest-news/johnson-johnson-caplyta-phase-3-bipolar-i-mania-second-trial 2026-11-12T22:01:05+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Johnson & Johnson Achieves Second Phase 3 Win for CAPLYTA in Bipolar I Mania Johnson & Johnson https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/579c44fc-df74-42c5-9d17-0f3c3d081697.png https://www.pharmanow.live/latest-news/fda-finalizes-gfi-273-durations-of-use-veterinary-antimicrobial-drugs-food-producing-animals 2026-11-12T22:03:37+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 FDA Finalizes GFI #273 Defining Durations of Use for Veterinary Antimicrobial Drugs in Food-Producing Animals FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/c7c0193b-eac7-4f2d-baeb-d0503e6df449.png https://www.pharmanow.live/latest-news/proqr-therapeutics-rna-editing-pipeline-phase-1-milestones-h1-2027 2026-11-12T22:07:01+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 ProQR Therapeutics Advances RNA Editing Pipeline ProQR https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/c0a11486-ace6-4951-86fe-8b35b031f4d0.png https://www.pharmanow.live/latest-news/fibrobiologics-expands-fibroblast-ip-portfolio-170-issued-patents 2026-11-12T22:09:20+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 FibroBiologics Expands Fibroblast IP Portfolio to 170 Issued Patents FibroBiologics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e5476608-dc78-44c5-b46e-3a8a626816ad/fd31184c-67b0-49db-b53c-8efba5a51455.png